Peripheral Nerve Injury Upper Limb

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Neuraptive Therapeutics
Neuraptive TherapeuticsPA - Chesterbrook
1 program
1
NTX-001Phase 31 trial
Active Trials
NCT06616025RecruitingEst. Apr 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
Neuraptive TherapeuticsNTX-001

Clinical Trials (1)

NCT06616025Neuraptive TherapeuticsNTX-001

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

Start: Feb 2025Est. completion: Apr 2027
Phase 3Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
1 companies competing in this space